Showing results (1-10 of 213) with videos related to
Sort By:
Pageof 22
ERJ Open Research|January 7, 2026
Is it time for a simplified method to evaluate airway eosinophilia?Patrizia Pignatti, Antonio SpanevelloJournal of Thoracic Disease|June 13, 2017
Is bronchodilator the correct treatment for COPD subjects before EBUS?Veronica Leoni, Patrizia Pignatti, Dina Visca, et al.Biomedicines|November 25, 2023
Brittle Asthma: Still on Board?Dina Visca, Francesco Ardesi, Rosella Centis, et al.International Journal of Chronic Obstructive Pulmonary Disease|July 1, 2015
Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary diseaseAndrea Zanini, Francesca Cherubino, Elisabetta Zampogna, et al.Respiration; International Review of Thoracic Diseases|November 3, 2022
Analysis of Patients with Asthma and Mixed Granulocytic Inflammatory Pattern in SputumPatrizia Pignatti, Dina Visca, Martina Zappa, et al.Frontiers in Allergy|April 24, 2026
Impact of sputum neutrophilia on the efficacy of biologics in severe asthmaPatrizia Pignatti, Martina Zappa, Francesco Ardesi, et al.Frontiers in Endocrinology|July 31, 2023
Thyroid hormones modifications among COVID-19 patients undergoing pulmonary rehabilitationLaura Croce, Elisabetta Zampogna, Francesca Coperchini, et al.Respiratory Research|July 12, 2019
Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patientsPatrizia Pignatti, Dina Visca, Francesca Cherubino, et al.Respiratory Care|February 17, 2021
The 5-Repetition Sit-to-Stand Test as an Outcome Measure for Pulmonary Rehabilitation in Subjects With AsthmaElisabetta Zampogna, Patrizia Pignatti, Nicolino Ambrosino, et al.European Journal of Internal Medicine|June 24, 2026
Neutrophil-to-lymphocyte ratio: A disease severity biomarker in stable chronic obstructive pulmonary disease?Marco Vanetti, Dina Visca, Francesco Ardesi, et al.Pageof 22